Processa Pharmaceuticals Inc (PCSA) — Strategic Asset Allocation Index
Processa Pharmaceuticals Inc (PCSA) has a Strategic Asset Allocation Index of 2.0% as of June 2023. Strategic assets (PP&E of $187.60K plus long-term investments of $-) total $187.60K, measured against net assets of $9.16 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Processa Pharmaceuticals Inc's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Processa Pharmaceuticals Inc Strategic Asset Allocation Index (2017–2021)
This chart shows how Processa Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2017 to 2021. As of June 2023, the index stands at 2.0%, representing strategic assets of $187.60K against net assets of $9.16 Million USD. For live market cap and overall valuation, see PCSA market cap.
Annual Strategic Asset Allocation Index for Processa Pharmaceuticals Inc (2017–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Processa Pharmaceuticals Inc from 2017 to 2021, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Processa Pharmaceuticals Inc for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.3% | $74.18K | $74.18K | $- | $25.49 Million | ▼ -0.4 pp |
| 2020 | 0.7% | $159.04K | $159.04K | $- | $22.94 Million | ▼ -2.2 pp |
| 2019 | 2.8% | $228.00K | $228.00K | $- | $8.01 Million | ▲ +2.7 pp |
| 2018 | 0.2% | $17.38K | $17.38K | $0.00 | $9.70 Million | ▼ -6.7 pp |
| 2017 | 6.9% | $25.82K | $25.82K | $0.00 | $373.16K | — |